Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pyrazino[2,3-d]isoxazole derivative

a technology of pyrazino[2,3-d]isoxazole and derivative, applied in the field of pyrazino2, 3disoxazole derivative, can solve the problems of special equipment and careful handling, and achieve the effect of safe and easy production

Active Publication Date: 2013-09-19
FUJIFILM TOYAMA CHEMICAL CO LTD
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention allows for the safe and easy production of certain products.

Problems solved by technology

However, since 3,6-difluoro-2-pyrazinecarbonitrile has high skin irritancy, and easily vaporizes due to low-molecular-weight liquid, it has had a manufacturing problem in that it requires special equipment and careful handling.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrazino[2,3-d]isoxazole derivative
  • Pyrazino[2,3-d]isoxazole derivative
  • Pyrazino[2,3-d]isoxazole derivative

Examples

Experimental program
Comparison scheme
Effect test

synthesis example 1

Synthesis of (B-1)

[0109]11.3 L of water and 1090 g of sodium hydroxide were added to a 30-L reaction vessel made of glass, and they were dissolved therein. To the obtained solution, 4000 g of (A-1) (the reagent of Tokyo Chemical Industry Co., Ltd.) was added, and the obtained mixture was then stirred at an internal temperature of 70° C. for 30 minutes. Thereafter, 2270 g of sodium chloride was added to the reaction solution and dissolved therein, and the obtained reaction mixture was then cooled to 0° C. or lower. 2270 mL of concentrated hydrochloric acid was slowly added to the reaction mixture, and 11.3 L of ethyl acetate was then added to the mixture. After completion of liquid separation, an aqueous layer was discarded. 11.3 L of a saturated saline was added to the obtained organic layer, and after completion of liquid separation, an aqueous layer was discarded. The obtained organic layer was concentrated under reduced pressure. To the thus obtained residue, 5.00 L of toluene wa...

synthesis example 2

Synthesis of (C-1)

[0111]1.48 kg (10.0 mol) of (B-1) was dissolved in 7.40 L of acetonitrile, and 1.10 kg (5.25 mol) of aminoacetonitrile sulfate was then added to the obtained solution. While keeping the internal temperature at 5° C. or lower, 1.91 kg (10.0 mol) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride was added to the mixture. While keeping the internal temperature at 0° C. to 6° C., 2.07 kg (20.0 mol) of triethylamine was added dropwise to the mixture over 90 minutes. The obtained reaction mixture was left at room temperature overnight. 3.00 L of water was added to the reaction mixture, and the solvent was then distilled away under reduced pressure. 7.40 L of ethyl acetate was added to the residue, and the obtained mixture was then stirred for 10 minutes. Thereafter, the reaction solution was left at rest, and an aqueous layer was then removed. The organic layer was cooled. Subsequently, while keeping the internal temperature at 6° C. or lower, approximately ...

synthesis example 3

Synthesis of (E-1)

[0113]Under a nitrogen atmosphere, 1.44 kg (12.8 mol) of potassium tert-butoxide was dissolved in 10.4 L of tetrahydrofuran. Thereafter, while keeping the internal temperature at 10° C. or lower, a solution of 2.08 kg (11.2 mol) of the (C-1) dissolved in 2.08 L of tetrahydrofuran was added dropwise to the solution over 1 hour. Subsequently, 1.58 kg (13.4 mol) of dimethyl oxalate was added to the solution, and the obtained mixture was then stirred at 40° C. for 2 hours. Thereafter, 16.0 L of methanol was further added to the reaction solution, followed by concentration, so as to obtain a methanol solution of (D-1). The thus obtained solution was directly used in the subsequent reaction.

[0114]1H-NMR (DMSO-d6) δ value: 1.15 (6H, t, J=7.2 Hz), 3.52-3.58 (4H, m), 3.60 (3H, s), 4.75 (1H, s), 7.88 (1H, br)

[0115]Under a nitrogen atmosphere, while keeping the internal temperature at 10° C. or lower, 0.979 L (13.2 mol) of trifluoroacetic acid was added dropwise to the obtain...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

The object of the present invention is to provide a compound which is useful as a production intermediate of pyrazine carboxamide derivative such as 6-fluoro-3-hydroxy-2-pyrazine carboxamide. The present invention provides a pyrazino[2,3-d]isoxazole derivative represented by the formula (I):wherein X represents a halogen atom, a hydroxyl group or a sulfamoyloxy group, and Y represents —C(═O)R or —CN; wherein R represents a hydrogen atom, an alkoxy group an aryloxy group, an alkyl group, an aryl group or an amino group.

Description

TECHNICAL FIELD[0001]The present invention relates to a pyrazino[2,3-d]isoxazole derivative that is useful as a production intermediate or the like of 6-fluoro-3-hydroxy-2-pyrazine carboxamide (hereinafter referred to as “T-705”) useful for treatment such as prevention and therapy of influenza virus infection, and a method for producing the same. In addition, the present invention relates to a method for producing a pyrazinecarbonitrile derivative and a pyrazinecarboxamide derivative using the pyrazino [2,3-d]isoxazole derivative.BACKGROUND ART[0002]T-705 is a compound useful for the prevention, treatment and the like of virus infection, and particularly, influenza virus infection. It has been known that T-705 is produced from, for example, 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile (hereinafter referred to as T-705A) (Patent Documents 1 and 2). Patent Document 2 describes that T-705A can be efficiently isolated in the form of salts with various amines.[0003]Examples of a known produ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D498/04C07D241/18C07D241/24C07C237/06
CPCC07D241/24C07D261/18C07D498/04C07C237/06C07C255/29C07C239/18C07C251/38C07C255/23C07D241/18
Inventor NAKAMURA, KOUKIMURAKAMI, TAKESHINAITOU, HIROYUKIHANAKI, NAOYUKIWATANABE, KATSUYUKI
Owner FUJIFILM TOYAMA CHEMICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com